Live Cell Encapsulation Market | Increasing Incidence of Target Diseases Driving The Market Growth
The live cell encapsulation market is projected to grow to USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2%
(IINews) - According to the new market research report "Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024", published by MarketsandMarkets™, the global Live Cell Encapsulation Market is projected to reach USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2%.
The major factors driving the growth of the Live Cell Encapsulation Market are the rising public awareness related to the clinical role of encapsulated cells in disease management, increasing public-private investments to support product development, and the rising adoption of novel drug delivery systems for disease treatment.
Don''t miss out on business opportunities in Live Cell Encapsulation Market.
Download an Illustrative overview of the report:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218019375
Simple dripping segment is expected to account for the largest share of the Live Cell Encapsulation Market, by manufacturing technique, in 2018
Based on manufacturing technique, the Live Cell Encapsulation Market is segmented into . The instruments segment is expected to account for the largest share of the Live Cell Encapsulation Market in 2019. The increasing adoption due to the procedural benefits (such as simple process, product biocompatibility, and low particle size distribution) are the major factors driving the growth of this market segment.
Browse in-depth TOC on "Live Cell Encapsulation Market"
64 – Tables
31 – Figures
138 – Pages
Alginate polymers segment estimated to be the fastest-growing polymer type segment during the forecast period
Based on polymer type, the Live Cell Encapsulation Market is segmented into alginate, HEMA-MMA (hydroxyethyl methacrylate-methyl methacrylate), chitosan, siliceous encapsulates, cellulose sulfate, PAN-PVC [poly (acrylonitrile vinyl chloride)], and other polymers. The alginate segment is expected to grow at the highest CAGR during the forecast period primarily due to the procedural benefits such as uniform cell structures and high mechanical stability.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=218019375
Drug delivery to account for the largest share of the Live Cell Encapsulation Market, by application, in 2018
Based on end user, the Live Cell Encapsulation Market is segmented into drug delivery, regenerative medicine, cell transplantation, probiotics, and research. Drug delivery are estimated to be the largest application of live cell encapsulation, and this trend is expected to continue during the forecast period. The large share of this application segment can be attributed to the ongoing technological advancements in the field of cell encapsulation and increased product affordability, and usage of biocompatible immobilization or isolation systems.
North America to dominate the Live Cell Encapsulation Market during the forecast period
The Live Cell Encapsulation Market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. North America is estimated to be the largest regional market for live cell encapsulation in 2019 majorly due to the increasing clinical data for the efficacy of the cell encapsulation technique and the rising adoption of cell encapsulation techniques among medical professionals.
Speak to Subject Expert:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=218019375
The major players operating in the Live Cell Encapsulation Market are BioTime, Inc. (US), Reed Pacific Pty Ltd. (Australia), Viacyte, Inc. (US), Neurotech Pharmaceuticals, Inc. (US), and Living Cell Technologies Ltd. (Australia) were the top five players in the global Live Cell Encapsulation Market. Other prominent players operating in this market include Merck KGAA (Germany), Sigilon Therapeutics, Inc. (US), Encapsys, LLC (US), Evonik Industries (Germany), Lycored (Israel), MiKroCaps (Slovenia), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), Sernova Corporation (Canada), and Balchem Corporation (US), among others.
Themen in diesem Fachartikel:
live-cell-encapsulation-market
live-cell-encapsulation-market-growth
live-cell-encapsulation-market-size
live-cell-encapsulation-market-analysis
live-cell-encapsulation-market-outlook
live-cell-encapsulation-market-business-news
live-cell
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies'' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets''s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 08.04.2019 - 09:39 Uhr
Sprache: Deutsch
News-ID 1712265
Anzahl Zeichen: 0
Kontakt-Informationen:
Ansprechpartner: Shelly Singh
Stadt:
Northbrook
Telefon: 18886006441
Kategorie:
Biotechnologie
Anmerkungen:
Dieser Fachartikel wurde bisher 183 mal aufgerufen.
Der Fachartikel mit dem Titel:
"Live Cell Encapsulation Market | Increasing Incidence of Target Diseases Driving The Market Growth
"
steht unter der journalistisch-redaktionellen Verantwortung von
MnM (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).